FibroBiologics Inc. (FBLG) vs Lunai Bioworks Inc. (LNAI)

FibroBiologics Inc. and Lunai Bioworks Inc. are both Biotechnology companies. FibroBiologics Inc. and Lunai Bioworks Inc. are of similar size ($9.1M and $8.8M). Across the 8 metrics below, FibroBiologics Inc. leads on 4 and Lunai Bioworks Inc. on 4.

Valuation

Metric FBLG LNAI Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.88 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (373.38%) (3,132.07%) (28.84%)
Free cash flow yield (172.63%) (86.80%) (23.03%)

Profitability

Metric FBLG LNAI Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (660.08%) (325.46%) (57.72%)
Return on assets (166.14%) (201.09%) (49.22%)
Return on invested capital (932.71%) 0.00% 0.00%

Growth

Metric FBLG LNAI Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (23.53%) (28.38%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric FBLG LNAI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.64 0.19 4.73
Net debt to EBITDA 0.31 0.03 0.96

Dividend

Metric FBLG LNAI Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric FBLG LNAI Biotechnology median
Market cap 9.06m 8.80m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack